Ignite Creation Date:
2024-05-06 @ 6:04 PM
Last Modification Date:
2024-10-26 @ 2:41 PM
Study NCT ID:
NCT05530889
Status:
WITHDRAWN
Last Update Posted:
2024-02-01
First Post:
2022-08-29
Brief Title:
Evaluating Quality of Life Benefits of ACUVUE Theravision With Ketotifen in Subjects With Ocular Allergies
Sponsor:
Johnson Johnson Vision Care Inc
Organization:
Johnson Johnson Vision Care Inc
Study Overview
Official Title:
Evaluating Quality of Life Benefits of ACUVUE Theravision With Ketotifen in Subjects With Ocular Allergies
Status:
WITHDRAWN
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Due to changes in business priorities CR-6494 has been withdrawn
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This will be a prospective randomized bilateral eye crossover non-masked single site pilot study to compare the severity of symptoms of itching between test and control lens after two weeks of wear
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None